We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$17.4B
AUM Growth
+$604M
Cap. Flow
-$350M
Cap. Flow %
-2.01%
Top 10 Hldgs %
29.23%
Holding
2,926
New
46
Increased
346
Reduced
1,409
Closed
76

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$18.5M
2
PLTR icon
Palantir
PLTR
+$14.9M
3
AVTR icon
Avantor
AVTR
+$8.33M
4
DELL icon
Dell
DELL
+$8.18M
5
AVGO icon
Broadcom
AVGO
+$6.3M

Sector Composition

Rank Sector Weight
1 Technology 29.85%
2 Financials 12.38%
3 Healthcare 11.45%
4 Consumer Discretionary 10.71%
5 Industrials 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCRN
2151
DELISTED
Cross Country Healthcare
CCRN
$260K ﹤0.01%
19,322
ADAM
2152
Adamas Trust
ADAM
$907M
$259K ﹤0.01%
40,854
-10,124
-20% -$65.2K
BBBY
2153
Bed Bath & Beyond
BBBY
$423M
$258K ﹤0.01%
28,173
KALV
2154
DELISTED
KalVista Pharmaceuticals
KALV
$258K ﹤0.01%
22,289
FPI
2155
Farmland Partners
FPI
$425M
$257K ﹤0.01%
24,635
-2,504
-9% -$26.5K
STOK icon
2156
Stoke Therapeutics
STOK
$2.02B
$256K ﹤0.01%
20,805
TWKS
2157
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$256K ﹤0.01%
57,816
ALT icon
2158
Altimmune
ALT
$560M
$255K ﹤0.01%
41,577
QTRX icon
2159
Quanterix
QTRX
$135M
$255K ﹤0.01%
19,680
XPER icon
2160
Xperi
XPER
$320M
$255K ﹤0.01%
27,572
URGN icon
2161
UroGen Pharma
URGN
$2.34B
$254K ﹤0.01%
20,039
NGNE icon
2162
Neurogene
NGNE
$713M
$254K ﹤0.01%
+6,054
New +$235K
U icon
2163
Unity
U
$20.2B
$254K ﹤0.01%
11,221
-228
-2% -$3.94K
KE
2164
Kimball Electronics
KE
$626M
$254K ﹤0.01%
13,706
HCP
2165
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$254K ﹤0.01%
7,491
+2,282
+44% +$77K
UFCS icon
2166
United Fire Group
UFCS
$1.38B
$252K ﹤0.01%
12,036
EE icon
2167
Excelerate Energy
EE
$1.12B
$250K ﹤0.01%
11,381
-355
-3% -$6.88K
EVGO icon
2168
EVgo
EVGO
$519M
$250K ﹤0.01%
60,491
PFIS icon
2169
Peoples Financial Services
PFIS
$717M
$250K ﹤0.01%
5,340
IVR icon
2170
Invesco Mortgage Capital
IVR
$805M
$250K ﹤0.01%
26,606
WLFC icon
2171
Willis Lease Finance
WLFC
$1.15B
$249K ﹤0.01%
5,022
AURA icon
2172
Aura Biosciences
AURA
$791M
$248K ﹤0.01%
27,785
ZIMV
2173
DELISTED
ZimVie
ZIMV
$247K ﹤0.01%
15,588
LYTS icon
2174
LSI Industries
LYTS
$912M
$247K ﹤0.01%
15,297
CLDT
2175
Chatham Lodging
CLDT
$601M
$247K ﹤0.01%
28,960
-9
-0% -$76

Similar funds

MetLife Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, MetLife Investment Management held 2,926 positions worth $17.4B, up 3.6% from $16.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 4.2%. MetLife Investment Management opened 46 new positions and exited 76, leaving the 2,926-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2024 buy was Smurfit Westrock: 128,702 shares worth $6.36M.
  • MetLife Investment Management added most to Apple in Q3 2024, an estimated $18.5M increase.
  • MetLife Investment Management's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $42.3M.
  • MetLife Investment Management fully exited Diamond Offshore Drilling, Inc. in Q3 2024, selling an estimated $6.15M.
  • MetLife Investment Management's ten largest holdings make up 29% of its $17.4B portfolio in Q3 2024.
  • MetLife Investment Management opened 46 new positions and closed 76 in Q3 2024.
  • MetLife Investment Management's portfolio value rose 3.6% quarter-over-quarter to $17.4B.

Based on MetLife Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.